Cargando…
SUN-179 Prolonged Hypoglycemia from Insulin Degludec
Prolonged Hypoglycemia from Insulin Degludec Background: Patients with type 2 diabetes treated with insulin degludec compared with insulin glargine had a reduced risk of overall symptomatic hypoglycemia (1). This is primarily due to former’s long half-life (25 hours) and lack of trough lev...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Endocrine Society
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553236/ http://dx.doi.org/10.1210/js.2019-SUN-179 |